Jasbir Seehra is President and Chief Executive Officer of Keros Therapeutics, Inc. (KROS). The company reported total compensation of $2,540,204 for fiscal year 2025.
| Salary | $700,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $1,426,280 |
| Option awards | $0 |
| Non-equity incentive plan | $398,125 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $15,799 |
| Total | $2,540,204 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Keros Therapeutics, Inc. filed April 22, 2026, accession 0001104659-26-046791.
| Peer-group chief executive median | $5,845,982 |
|---|---|
| Difference from that median | $-3,305,778 |
| Percentile within the disclosed peer group | 16th |
| Peers with a disclosed figure | 18 |
Medians and percentiles are computed across the peer group Keros Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Jasbir Seehra this page | President and Chief Executive Officer | $2,540,204 |
| Christopher Rovaldi | Former President and Chief Operating Officer | $1,476,114 |
| Keith Regnante | Chief Financial Officer | $1,113,872 |
| Esther Cho | Chief Legal Officer and Secretary | $1,098,832 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Keros Therapeutics, Inc. compensation brief.
Jasbir Seehra's compensation sits inside Keros Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.